Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Minerva Medica
|
May 15, 2025
Endoscopic ultrasound with bronchoscope fine-needle biopsy in the diagnosis of suspected malignant pulmonary lesions with crown-cut needle: a retrospective study
Filippo Lanfranchi, Gioele Castelli, Giacomo Giulianelli, et al.
NPJ Precision Oncology
|
October 17, 2024
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer
Andrea Boscolo Bragadin, Paola Del Bianco, Elisabetta Zulato, et al.
The Oncologist
|
April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors
Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
The Oncologist
|
May 31, 2022
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome
Alberto Pavan, Alessandra Ferro, Francesco Fortarezza, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment
Anna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Frontiers in Immunology
|
February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis
Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Peerj
|
August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
Zoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.
British Journal of Cancer
|
September 29, 2022
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
Elisabetta Zulato, Paola Del Bianco, Giorgia Nardo, et al.
Oncotarget
|
April 22, 2017
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
Stefano Frega, Martina Lorenzi, Matteo Fassan, et al.
Protein Science : a Publication of the Protein Society
|
August 16, 2024
Structural adaptability and surface activity of peptides derived from tardigrade proteins
Giulia Giubertoni, Sarah Chagri, Pablo G Argudo, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Minerva Medica
|
May 15, 2025
Endoscopic ultrasound with bronchoscope fine-needle biopsy in the diagnosis of suspected malignant pulmonary lesions with crown-cut needle: a retrospective study
Filippo Lanfranchi, Gioele Castelli, Giacomo Giulianelli, et al.
NPJ Precision Oncology
|
October 17, 2024
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer
Andrea Boscolo Bragadin, Paola Del Bianco, Elisabetta Zulato, et al.
The Oncologist
|
April 25, 2019
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors
Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al.
The Oncologist
|
May 31, 2022
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome
Alberto Pavan, Alessandra Ferro, Francesco Fortarezza, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment
Anna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Frontiers in Immunology
|
February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis
Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Peerj
|
August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
Zoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.
British Journal of Cancer
|
September 29, 2022
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
Elisabetta Zulato, Paola Del Bianco, Giorgia Nardo, et al.
Oncotarget
|
April 22, 2017
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
Stefano Frega, Martina Lorenzi, Matteo Fassan, et al.
Protein Science : a Publication of the Protein Society
|
August 16, 2024
Structural adaptability and surface activity of peptides derived from tardigrade proteins
Giulia Giubertoni, Sarah Chagri, Pablo G Argudo, et al.
Page
of 4